Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: Implications for dilated cardiomyopathy

International Journal of Cardiology

Volumn 131, Issue 2, 2009, Pages 246-256

  Athanassopoulos, Petros ^a   Balk, Aggie H M M ^a   Vaessen, Leonard M B ^a   Caliskan, Kadir ^a   Takkenberg, Johanna J M ^a   Weimar, Willem ^a   Bogers, Ad J J C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Blood; Dendritic cells; Dilated cardiomyopathy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CD83 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR7; COUMARIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DENDRITIC CELL; DIASTOLIC DYSFUNCTION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART FAILURE; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMMUNE RESPONSE; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTOLIC DYSFUNCTION;

ADULT; AGED; CARDIOMYOPATHY, DILATED; CROSS-SECTIONAL STUDIES; DENDRITIC CELLS; FEMALE; HEART FAILURE; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED;

EID: 57649088934     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.10.031     Document Type: Article

References (52)

1. Bristow M.R. Why does the myocardium fail? Insights from basic science. Lancet 352 Suppl 1 (1998) SI8-SI14
2. Mobini R., Maschke H., and Waagstein F. New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy. Autoimmun Rev 3 4 (2004) 277-284
3. Stevenson L.W., and Perloff J.K. The dilated cardiomyopathies: clinical aspects. Cardiol Clin 6 2 (1988) 187-218
4. McKenna C.J., Codd M.B., McCann H.A., and Sugrue D.D. Idiopathic dilated cardiomyopathy: familial prevalence and HLA distribution. Heart 77 6 (1997) 549-552
5. Braz J.C., Gregory K., Pathak A., et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med 10 3 (2004) 248-254
6. Matsumoto Y., Tsukada Y., Miyakoshi A., Sakuma H., and Kohyama K. C protein-induced myocarditis and subsequent dilated cardiomyopathy: rescue from death and prevention of dilated cardiomyopathy by chemokine receptor DNA therapy. J Immunol 173 5 (2004) 3535-3541
7. Haghighi K., Gregory K.N., and Kranias E.G. Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy. Biochem Biophys Res Commun 322 4 (2004) 1214-1222
8. Holzinger C., Schollhammer A., Imhof M., et al. Phenotypic patterns of mononuclear cells in dilated cardiomyopathy. Circulation 92 10 (1995) 2876-2885
9. Noutsias M., Pauschinger M., Schultheiss H., and U K.h. Phenotypic characterization of infiltrates in dilated cardiomyopathy-diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy. Med Sci Monit 8 7 (2002) CR478-CR487
10. Fujioka S., Kitaura Y., Deguchi H., et al. Evidence of viral infection in the myocardium of American and Japanese patients with idiopathic dilated cardiomyopathy. Am J Cardiol 94 5 (2004) 602-605
11. Fairweather D., Kaya Z., Shellam G.R., Lawson C.M., and Rose N.R. From infection to autoimmunity. J Autoimmun 16 3 (2001) 175-186
12. Huber S.A., Sartini D., and Exley M. Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells. J Virol 76 21 (2002) 10785-10790
13. Kishimoto C., Hiraoka Y., Takamatsu N., Takada H., Kamiya H., and Ochiai H. An in vivo model of autoimmune post-coxsackievirus B3 myocarditis in severe combined immunodeficiency mouse. Cardiovasc Res 60 2 (2003) 397-403
14. Ludewig B., Krebs P., Junt T., and Bocharov G. Dendritic cell homeostasis in the regulation of self-reactivity. Curr Pharm Des 9 3 (2003) 221-231
15. Pulendran B., Palucka K., and Banchereau J. Sensing pathogens and tuning immune responses. Science 293 5528 (2001) 253-256
16. Marty R.R., and Eriksson U. Dendritic cells and autoimmune heart failure. Int J Cardiol 112 1 (2006) 34-39
17. Eriksson U., Ricci R., Hunziker L., et al. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 9 12 (2003) 1484-1490
18. Afanasyeva M., Georgakopoulos D., Belardi D.F., et al. Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function. Am J Pathol 164 3 (2004) 807-815
19. Kohrgruber N., Halanek N., Groger M., et al. Survival, maturation, and function of CD11c-and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. J Immunol 163 6 (1999) 3250-3259
20. Thomas R., MacDonald K.P., Pettit A.R., Cavanagh L.L., Padmanabha J., and Zehntner S. Dendritic cells and the pathogenesis of rheumatoid arthritis. J Leukoc Biol 66 2 (1999) 286-292
21. Siegal F.P., Kadowaki N., Shodell M., et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 284 5421 (1999) 1835-1837
22. Mohty M., Jarrossay D., Lafage-Pochitaloff M., et al. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood 98 13 (2001) 3750-3756
23. Kuwana M. Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets. Hum Immunol 63 12 (2002) 1156-1163
24. Banchereau J., Briere F., Caux C., et al. Immunobiology of dendritic cells. Annu Rev Immunol 18 (2000) 767-811
25. Sallusto F., Palermo B., Lenig D., et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 29 5 (1999) 1617-1625
26. de Leeuw N., Ruiter D.J., Balk A.H., de Jonge N., Melchers W.J., and Galama J.M. Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int 14 5 (2001) 299-306
27. Verduyn W., Doxiadis II, Anholts J., et al. Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant. Hum Immunol 37 1 (1993) 59-67
28. Schreuder G.M., Hurley C.K., Marsh S.G., et al. HLA dictionary 2004: summary of HLA-A,-B,-C,-DRB1/3/4/5,-DQB1 alleles and their association with serologically defined HLA-A,-B,-C,-DR, and-DQ antigens. Hum Immunol 66 2 (2005) 170-210
29. Senni M., Tribouilloy C.M., Rodeheffer R.J., et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 98 21 (1998) 2282-2289
30. Zile M.R., and Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105 11 (2002) 1387-1393
31. Athanassopoulos P., Vaessen L.M., Balk A.H., et al. Impaired circulating dendritic cell reconstitution identifies rejecting recipients after clinical heart transplantation independent of rejection therapy. Eur J Cardio-Thorac Surg 27 5 (2005) 783-789
32. Athanassopoulos P., Vaessen L.M., Maat A.P., et al. Preferential depletion of blood myeloid dendritic cells during acute cardiac allograft rejection under controlled immunosuppression. Am J Transplant 5 4 (2005) 810-820
33. Schwartz A., Gaigalas A.K., Wang L., Marti G.E., Vogt R.F., and Fernandez-Repollet E. Formalization of the MESF unit of fluorescence intensity. Cytom B Clin Cytom 57 1 (2004) 1-6
34. Athanassopoulos P., Vaessen L.M., Maat A.P., Balk A.H., Weimar W., and Bogers A.J. Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responses. Eur J Cardio-Thorac Surg 25 4 (2004) 619-626
35. Della Bella S., Bierti L., Presicce P., et al. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin Immunol 122 2 (2007) 220-228
36. Shodell M., and Siegal F.P. Circulating, interferon-producing plasmacytoid dendritic cells decline during human ageing. Scand J Immunol 56 5 (2002) 518-521
37. Hung M.J., and Cherng W.J. Comparison of white blood cell counts in acute myocardial infarction patients with significant versus insignificant coronary artery disease. Am J Cardiol 91 11 (2003) 1339-1342
38. Andrew P. Diastolic heart failure demystified. Chest 124 2 (2003) 744-753
39. Hasper D., Hummel M., Kleber F.X., Reindl I., and Volk H.D. Systemic inflammation in patients with heart failure. Eur Heart J 19 5 (1998) 761-765
40. Fairweather D., Yusung S., Frisancho S., et al. IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta-and IL-18-associated myocarditis and coxsackievirus replication. J Immunol 170 9 (2003) 4731-4737
41. Borda E., Pascual J., Cossio P., De La Vega M., Arana R., and Sterin-Borda L. A circulating IgG in Chagas' disease which binds to beta-adrenoceptors of myocardium and modulates their activity. Clin Exp Immunol 57 3 (1984) 679-686
42. Smith S.C., and Allen P.M. Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. Proc Natl Acad Sci U S A 89 19 (1992) 9131-9135
43. Okazaki T., Tanaka Y., Nishio R., et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 9 12 (2003) 1477-1483
44. Knowlton A.A., Kapadia S., Torre-Amione G., et al. Differential expression of heat shock proteins in normal and failing human hearts. J Mol Cell Cardiol 30 4 (1998) 811-818
45. Tanonaka K., Yoshida H., Toga W., Furuhama K., and Takeo S. Myocardial heat shock proteins during the development of heart failure. Biochem Biophys Res Commun 283 2 (2001) 520-525
46. Portig I., Pankuweit S., and Maisch B. Antibodies against stress proteins in sera of patients with dilated cardiomyopathy. J Mol Cell Cardiol 29 8 (1997) 2245-2251
47. Wan T., Zhou X., Chen G., et al. Novel heat shock protein Hsp70 L1 activates dendritic cells and acts as a Th1 polarizing adjuvant. Blood 103 5 (2004) 1747-1754
48. Flohe S.B., Bruggemann J., Lendemans S., et al. Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J Immunol 170 5 (2003) 2340-2348
49. Gomez J., Borras F.E., Singh R., et al. Differential up-regulation of HLA-DM, invariant chain, and CD83 on myeloid and plasmacytoid dendritic cells from peripheral blood. Tissue Antigens 63 2 (2004) 149-157
50. Sallusto F., and Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med 189 4 (1999) 611-614
51. MacLellan W.R., and Lusis A.J. Dilated cardiomyopathy: learning to live with yourself. Nat Med 9 12 (2003) 1455-1456
52. de Leeuw N., Melchers W.J., Ruiter D.J., et al. Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy. J Clin Pathol 52 10 (1999) 739-743